Iteos Therapeutics Inc expected to post a loss of $1.26 a share - Earnings Preview

iTeos Therapeutics

06/05/2024 17:29

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 8
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Iteos Therapeutics Inc
is for
a loss of $1.26 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 96.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $40.00​, above​ its last closing price
of $11.66. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.93       -1.03      -0.85     Beat    17.7
 Sep. 30 2023  -1.14       -1.20      -0.90     Beat    25.2
 Jun. 30 2023  -0.98       -1.03      -0.96     Beat    6.8​
 Mar. 31 2023  -1.00       -0.99      -0.44     Beat    55.8
 ​​Dec.                    0.33                         
 31 2022                                                
 Sep. 30 2022  0.11        0.10       0.03      Missed  -69.2​
 Jan. 1 0001   1.13        1.20       0.15      Missed  -87.5
 Mar. 31 2022  0.79        0.80       1.82      Beat    128.9
 This summary was machine generated May 6 at 16:29 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)